We found that the high impact mutations in JMJD1C, SLA, PDZD2, identified from in-silico analysis in PTC samples, are missing in the thyroid cancer cell lines analyzed, thus suggesting that the altered expression of these genes is due to other regulative biological mechanisms. This evidence concerns the gene JMJD1C and thyroid gland carcinoma.